359 related articles for article (PubMed ID: 16732585)
1. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
Hirschl M; Hirschl K; Lenz M; Katzenschlager R; Hutter HP; Kundi M
Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
[TBL] [Abstract][Full Text] [Related]
2. Initial prevalence and incidence of secondary Raynaud's phenomenon in patients with Raynaud's symptomatology.
Hirschl M; Kundi M
J Rheumatol; 1996 Feb; 23(2):302-9. PubMed ID: 8882036
[TBL] [Abstract][Full Text] [Related]
3. Incidence of thoracic outlet syndrome on the epidemiology and clinical presentation of apparently primary Raynaud's phenomenon. A prospective study in 570 patients.
Pistorius MA; Planchon B
Int Angiol; 1995 Mar; 14(1):60-4. PubMed ID: 7658106
[TBL] [Abstract][Full Text] [Related]
4. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
Stoyneva Z
Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
[TBL] [Abstract][Full Text] [Related]
5. Need to expand microvascular investigation of patients with Raynaud's phenomenon of different etiology: clinical patterns of 106 consecutive patients.
Arpaia G; Cimminiello C; Bellone M; Aloisio M; Rossi F; Bonfardeci G
Int Angiol; 1994 Mar; 13(1):15-8. PubMed ID: 8077792
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary function in patients presenting with Raynaud's phenomenon without an underlying connective tissue disease. A prospective, longitudinal study.
Aalbers R; Groen H; Postma DS; Van der Mark TW; Wouda AA; Reig RP; Kallenberg CG
J Rheumatol; 1989 Jan; 16(1):36-41. PubMed ID: 2785598
[TBL] [Abstract][Full Text] [Related]
8. Raynaud's phenomenon: clinical spectrum of 118 patients.
De Angelis R; Del Medico P; Blasetti P; Cervini C
Clin Rheumatol; 2003 Oct; 22(4-5):279-84. PubMed ID: 14576990
[TBL] [Abstract][Full Text] [Related]
9. Early detection of connective tissue disease in patients with Raynaud's phenomenon.
Kallenberg CG
Rheum Dis Clin North Am; 1990 Feb; 16(1):11-30. PubMed ID: 2406802
[TBL] [Abstract][Full Text] [Related]
10. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
Rychlik-Golema W; Mastej K; Adamiec R
Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
[TBL] [Abstract][Full Text] [Related]
11. [Raynaud's phenomenon; diagnosis and treatment].
Hofstee HM; Voskuyl AE; Serné EH; Smulders YM
Ned Tijdschr Geneeskd; 2009; 153():B216. PubMed ID: 19785782
[TBL] [Abstract][Full Text] [Related]
12. Raynaud's phenomenon as an early sign of connective tissue diseases.
Kallenberg CG
Vasa Suppl; 1992; 34():25-8. PubMed ID: 1529414
[TBL] [Abstract][Full Text] [Related]
13. [Raynaud phenomenon in childhood: review and progress control in eight cases].
González Pascual E; Esquinas Rychen G; Ruiz España A; Ros Viladoms JB; Juanola Roura X
An Esp Pediatr; 1998 Jun; 48(6):603-7. PubMed ID: 9662844
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon.
Porciello G; Scarpato R; Ferri C; Storino F; Cagetti F; Morozzi G; Bellisai F; Migliore L; Marcolongo R; Galeazzi M
J Rheumatol; 2003 Jun; 30(6):1244-7. PubMed ID: 12784397
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of clinical signs and symptoms in patients with Raynaud's phenomenon. A cross-sectional study.
Wollersheim H; Thien T
Neth J Med; 1990 Dec; 37(5-6):171-82. PubMed ID: 2074908
[TBL] [Abstract][Full Text] [Related]
16. Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination).
Ingegnoli F; Boracchi P; Gualtierotti R; Lubatti C; Meani L; Zahalkova L; Zeni S; Fantini F
Arthritis Rheum; 2008 Jul; 58(7):2174-82. PubMed ID: 18576359
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease.
Houtman PM; Kallenberg CG; Fidler V; Wouda AA
J Rheumatol; 1986 Jun; 13(3):556-63. PubMed ID: 3735277
[TBL] [Abstract][Full Text] [Related]
18. [Indications for nailbed capillaroscopy in Raynaud's phenomenon].
Chamot AM; Monti M
Schweiz Med Wochenschr; 1985 Dec; 115(51):1852-7. PubMed ID: 4089584
[TBL] [Abstract][Full Text] [Related]
19. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
Myckatyn SO; Russell AS
J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
[TBL] [Abstract][Full Text] [Related]
20. Thermographic parameters in the diagnosis of secondary Raynaud's phenomenon.
Schuhfried O; Vacariu G; Lang T; Korpan M; Kiener HP; Fialka-Moser V
Arch Phys Med Rehabil; 2000 Apr; 81(4):495-9. PubMed ID: 10768542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
